Sharma S - Search Results

1

Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer.

Kemeny N, Tong W, Gonen M, Stockman J, Di Lauro C, Teitcher J, White P, Price C, Saltz L, Sharma S, Graham MA. Kemeny N, et al. Among authors: sharma s. Ann Oncol. 2002 Sep;13(9):1490-6. doi: 10.1093/annonc/mdf247. Ann Oncol. 2002. PMID: 12196376 Free article. Clinical Trial.

2

A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan.

Sharma S, Kemeny N, Kelsen DP, Ilson D, O'Reilly E, Zaknoen S, Baum C, Statkevich P, Hollywood E, Zhu Y, Saltz LB. Sharma S, et al. Ann Oncol. 2002 Jul;13(7):1067-71. doi: 10.1093/annonc/mdf173. Ann Oncol. 2002. PMID: 12176785 Free article. Clinical Trial.

3

Oral chemotherapeutic agents for colorectal cancer.

Sharma S, Saltz LB. Sharma S, et al. Oncologist. 2000;5(2):99-107. doi: 10.1634/theoncologist.5-2-99. Oncologist. 2000. PMID: 10794800 Free article. Review.

4

Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.

Culliford AT 4th, Brooks AD, Sharma S, Saltz LB, Schwartz GK, O'Reilly EM, Ilson DH, Kemeny NE, Kelsen DP, Guillem JG, Wong WD, Cohen AM, Paty PB. Culliford AT 4th, et al. Among authors: sharma s. Ann Surg Oncol. 2001 Dec;8(10):787-95. doi: 10.1007/s10434-001-0787-9. Ann Surg Oncol. 2001. PMID: 11776492

5

Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.

Sharma S, Kemeny N, Schwartz GK, Kelsen D, O'Reilly E, Ilson D, Coyle J, De Jager RL, Ducharme MP, Kleban S, Hollywood E, Saltz LB. Sharma S, et al. Clin Cancer Res. 2001 Dec;7(12):3963-70. Clin Cancer Res. 2001. PMID: 11751488 Clinical Trial.

6

A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors.

Sharma S, Abhyankar V, Burgess RE, Infante J, Trowbridge RC, Tarazi J, Kim S, Tortorici M, Chen Y, Robles RL. Sharma S, et al. Ann Oncol. 2010 Feb;21(2):297-304. doi: 10.1093/annonc/mdp489. Epub 2009 Nov 25. Ann Oncol. 2010. PMID: 19940012 Free article. Clinical Trial.

7

Postoperative adjuvant chemotherapy for operable esophageal cancer: a pilot clinical study.

Sharma S, D'Cruz AK, Kannan R, Vyas JJ. Sharma S, et al. J Surg Oncol. 1992 Jun;50(2):101-4. doi: 10.1002/jso.2930500209. J Surg Oncol. 1992. PMID: 1593879

8

Patient selection for oral chemotherapy.

Sharma S. Sharma S. Oncology (Williston Park). 2001 Jan;15(1 Suppl 2):33-5. Oncology (Williston Park). 2001. PMID: 11219975 Free article. Review.

9

Combined treatment modalities in esophageal cancer.

Desai PB, Vyas JJ, Sharma S, Deshpande RK, Badwe RA, Advani SH, Saikia T, Dinshaw KA, Santhi Swaroop V. Desai PB, et al. Among authors: sharma s. Semin Surg Oncol. 1989;5(5):365-9. doi: 10.1002/ssu.2980050515. Semin Surg Oncol. 1989. PMID: 2814149

10

Intermediate-dose methotrexate and cisplatin in the treatment of advanced epidermoid esophageal carcinoma. Response rate and disease-free survival.

Saikia TK, Advani SH, Ramakrishnan G, Swaroop S, Sharma S, Desai PB. Saikia TK, et al. Among authors: sharma s. Cancer. 1989 Jul 15;64(2):371-3. doi: 10.1002/1097-0142(19890715)64:2<371::aid-cncr2820640205>3.0.co;2-1. Cancer. 1989. PMID: 2736483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,302 results

Search Page

Filters